AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR+53.5%
5Y CAGR+14.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+53.5%/yr
Quarterly compound
5Y CAGR
+14.7%/yr
Recent acceleration
Percentile
P69
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 8.57% |
| Q3 2025 | -1.11% |
| Q2 2025 | 4.14% |
| Q1 2025 | 12.22% |
| Q4 2024 | -15.58% |
| Q3 2024 | 39.36% |
| Q2 2024 | -6.99% |
| Q1 2024 | 10.63% |
| Q4 2023 | -1.63% |
| Q3 2023 | -1.79% |
| Q2 2023 | 16.37% |
| Q1 2023 | -24.44% |
| Q4 2022 | 2.37% |
| Q3 2022 | 29.48% |
| Q2 2022 | 3.45% |
| Q1 2022 | 9.03% |
| Q4 2021 | 1.32% |
| Q3 2021 | 4.54% |
| Q2 2021 | 2.21% |
| Q1 2021 | 10.03% |
| Q4 2020 | 4.31% |
| Q3 2020 | -3.87% |
| Q2 2020 | 2.17% |
| Q1 2020 | 10.40% |
| Q4 2019 | 2.53% |
| Q3 2019 | -0.77% |
| Q2 2019 | -6.84% |
| Q1 2019 | 12.62% |
| Q4 2018 | 6.65% |
| Q3 2018 | 0.93% |
| Q2 2018 | -12.31% |
| Q1 2018 | 25.49% |
| Q4 2017 | 6.49% |
| Q3 2017 | 3.16% |
| Q2 2017 | 0.66% |
| Q1 2017 | 11.20% |
| Q4 2016 | 7.32% |
| Q3 2016 | 2.62% |
| Q2 2016 | -21.28% |
| Q1 2016 | 37.62% |